EmailScribe AI

Abstract

EmailScribe AI is a purpose-built module within the Health LifeSciences AI platform that automates the end-to-end processing of safety-related emails. By integrating directly with safety mailboxes, the system fetches, reads, and extracts content from email bodies and attachments (PDFs, Word, Images) to perform automated triage.

It converts unstructured correspondence into regulatory-ready data—including translation, classification, and field extraction—within seconds. When incoming information is incomplete, the system automatically initiates a structured follow-up sequence to close the data gap without manual intervention. This transformation allows pharmacovigilance teams to move from hours of manual intake to a scalable, automated workflow that meets strict global reporting timelines. AI-Powered Email Management.

1. Introduction

Email remains a primary channel for safety information, but it presents a massive operational burden. Every incoming message from a healthcare professional or patient requires a complex series of decisions: Is it an adverse event? Is it serious? Does it require translation? Is the information complete enough to proceed? Manual processing of these variables is slow, inconsistent, and difficult to scale, often leading to backlogs that threaten compliance with FDA, EMA, and MHRA timelines.

EmailScribe AI addresses this "email burden" by providing an intelligent head start, ensuring that serious cases are identified, triaged, and actively followed up within seconds rather than days.

2. Solution Overview

The solution operates as an automated intake and correspondence layer that connects directly to safety mailboxes through secure API integrations (such as Microsoft Outlook/Azure AD).

• Automated Retrieval: The system fetches unread emails and all associated attachments from configured folders without modifying or deleting original records.
• Unified Processing: It converts HTML email bodies and document attachments into a unified text block for holistic analysis.
• Intelligent Triage: Emails are categorized into four pharmacovigilance-relevant categories: Adverse Event (AE), Medical Inquiry (MI), Product Quality Complaint (PQC), or Administrative Correspondence.
• Seriousness Assessment: The system determines the seriousness of each case based on established clinical criteria (e.g., hospitalization, life-threatening) and provides a mandatory written rationale.
• Automated Follow-Up: When triage reveals an incomplete case—missing patient details, dosage information, or outcome data—the system automatically generates and schedules a sequence of targeted follow-up emails to the original reporter, tracking replies and escalating tone with each unanswered attempt.

3. Business Impact

EmailScribe AI delivers a measurable shift in safety operations, reducing the manual triage and follow-up burden by over 90%:

• Operational Efficiency: A team processing 100 emails per day can reduce their manual effort from 140 hours to just 4-8 hours of validation time, including follow-up correspondence that previously required individual manual drafting.
• Risk Reduction: Automated classification eliminates human "Friday afternoon fatigue" and ensures that serious cases are flagged immediately for expedited reporting. Automated follow-up ensures no incomplete case is silently abandoned.
• Cost Savings: By automating translation, transcription, and follow-up drafting, organizations can significantly reduce third-party outsourcing costs and the need for temporary staffing during volume surges.
• Audit Readiness: Every decision, classification, follow-up action, and timestamp is captured in real-time, allowing for instant export of complete processing histories—including the full correspondence thread—for regulatory inspections.

4. Product Objectives

The module is designed to achieve the following functional benchmarks in safety intake:

• Direct Integration: Seamlessly connect to safety mailboxes to eliminate manual file movement.
• Multilingual Detection: Automatically detect source languages and translate content to English while preserving medical context.
• Attachment Intelligence: Extract and analyze text from within PDFs, Word documents, and images attached to the email.
• Narrative Generation: Produce structured pharmacovigilance narratives ready for case documentation.
• Structured Extraction: Pull key data points (patient name, product, dosage, AE terms) into a ready-to-export format.
• Intelligent Follow-Up: Automatically generate and manage a complete follow-up correspondence sequence for cases where critical information is missing, with each draft informed by the full conversation history to date.

5. Process Architecture and Flow

• Connection & Fetch: The system queries designated folders via secure API to retrieve unread messages and attachments.
• Analysis & Translation: The AI reads the entire context (subject, body, and files), translating non-English content while keeping the original text for verification.
• Review Interface: Reviewers utilize a clean three-column display—Original, Translation, and AI Triage Summary—to see the full picture at a glance.
• Validation & Adjustment: Humans-in-the-loop verify the AI-suggested category, seriousness, and extracted fields. Upon triage verification, the system immediately drafts the first targeted follow-up email if required information is missing.
• Automated Follow-Up Sequence: Follow-ups are generated one at a time, with each draft incorporating the complete prior conversation—including all sent messages and any replies received—so that each new message targets only what remains outstanding.
• Export: One-click generation of formatted Excel reports or other structured formats for downstream safety database import, with the full follow-up correspondence thread included as part of the case record.

6. Technology Stack

EmailScribe AI utilizes a secure, enterprise-grade architecture that integrates with existing IT ecosystems:

• Connectivity: Secure API integration with Microsoft Outlook and Azure Active Directory for registered application access, or any mailboxes and custom connectors provided by the client.
• AI Engines: Powered by advanced Generative AI, NLP, and vision models for contextual understanding, document extraction, and conversational follow-up drafting.
• Deployment: Flexible options include managed cloud deployment with regional data residency or on-premise installation for maximum data control.

7. Decision Logic and Governance

Governance is fundamental to the platform's regulatory alignment, ensuring every automated step—including follow-up correspondence—is traceable and validated:

• Human-in-the-Loop: The AI does not make final regulatory decisions or send correspondence autonomously; it assists reviewers who provide the final validation and approval at every stage, including follow-up sends.
• Traceable Rationale: Every seriousness decision includes a written explanation of which criteria were met, providing evidence for quality reviews. Every follow-up action, edit, and send is logged against the originating case record.
• Compliance Alignment: Supports ICH E2B(R3) and 21 CFR Part 11.
• Configurable Rules: The system is tailored to each client's specific Standard Operating Procedures (SOPs), product-specific classification nuances, and follow-up scheduling cadences.